

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 9.03317401 |
| 2 | urate metabolic process (GO:0046415) | 9.02526911 |
| 3 | aminoglycoside antibiotic metabolic process (GO:0030647) | 8.55835820 |
| 4 | phosphate ion transport (GO:0006817) | 8.48632545 |
| 5 | regulation of guanylate cyclase activity (GO:0031282) | 8.22632260 |
| 6 | angiotensin maturation (GO:0002003) | 7.74409249 |
| 7 | phosphate ion transmembrane transport (GO:0035435) | 7.73690130 |
| 8 | drug transport (GO:0015893) | 7.67002828 |
| 9 | cellular glucuronidation (GO:0052695) | 7.54870907 |
| 10 | lysine metabolic process (GO:0006553) | 7.54482897 |
| 11 | lysine catabolic process (GO:0006554) | 7.54482897 |
| 12 | positive regulation of guanylate cyclase activity (GO:0031284) | 7.26313844 |
| 13 | glucuronate metabolic process (GO:0019585) | 7.23718956 |
| 14 | uronic acid metabolic process (GO:0006063) | 7.23718956 |
| 15 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.12364020 |
| 16 | organic cation transport (GO:0015695) | 7.12123308 |
| 17 | regulation of bile acid biosynthetic process (GO:0070857) | 6.46165813 |
| 18 | cysteine metabolic process (GO:0006534) | 6.40660484 |
| 19 | drug catabolic process (GO:0042737) | 6.18075717 |
| 20 | epoxygenase P450 pathway (GO:0019373) | 6.09659546 |
| 21 | flavonoid metabolic process (GO:0009812) | 5.77690274 |
| 22 | peptide catabolic process (GO:0043171) | 5.74285387 |
| 23 | glyoxylate metabolic process (GO:0046487) | 5.73443992 |
| 24 | intestinal absorption (GO:0050892) | 5.72433027 |
| 25 | exogenous drug catabolic process (GO:0042738) | 5.69472434 |
| 26 | surfactant homeostasis (GO:0043129) | 5.61331313 |
| 27 | quaternary ammonium group transport (GO:0015697) | 5.60282550 |
| 28 | excretion (GO:0007588) | 5.47407976 |
| 29 | lipoprotein transport (GO:0042953) | 5.45986201 |
| 30 | branched-chain amino acid metabolic process (GO:0009081) | 5.44250834 |
| 31 | homocysteine metabolic process (GO:0050667) | 5.40438246 |
| 32 | regulation of cGMP biosynthetic process (GO:0030826) | 5.39718925 |
| 33 | response to mercury ion (GO:0046689) | 5.36297285 |
| 34 | bile acid and bile salt transport (GO:0015721) | 5.24004123 |
| 35 | tricarboxylic acid metabolic process (GO:0072350) | 5.23683247 |
| 36 | aspartate family amino acid catabolic process (GO:0009068) | 5.19358330 |
| 37 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.15097938 |
| 38 | short-chain fatty acid metabolic process (GO:0046459) | 5.13410213 |
| 39 | renal absorption (GO:0070293) | 5.09559821 |
| 40 | vitamin D metabolic process (GO:0042359) | 5.05068929 |
| 41 | valine metabolic process (GO:0006573) | 5.02343733 |
| 42 | branched-chain amino acid catabolic process (GO:0009083) | 4.75738814 |
| 43 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.73296852 |
| 44 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.73296852 |
| 45 | endocrine process (GO:0050886) | 4.73296852 |
| 46 | trivalent inorganic anion homeostasis (GO:0072506) | 4.71304866 |
| 47 | phosphate ion homeostasis (GO:0055062) | 4.71304866 |
| 48 | positive regulation of cGMP biosynthetic process (GO:0030828) | 4.65140263 |
| 49 | toxin transport (GO:1901998) | 4.58908163 |
| 50 | glutathione biosynthetic process (GO:0006750) | 4.56094764 |
| 51 | proline metabolic process (GO:0006560) | 4.53955615 |
| 52 | L-phenylalanine metabolic process (GO:0006558) | 4.49530270 |
| 53 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.49530270 |
| 54 | chemical homeostasis within a tissue (GO:0048875) | 4.48952575 |
| 55 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.48743600 |
| 56 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.47868679 |
| 57 | cellular ketone body metabolic process (GO:0046950) | 4.45619721 |
| 58 | metanephric nephron tubule development (GO:0072234) | 4.45141945 |
| 59 | metanephric tubule development (GO:0072170) | 4.45141945 |
| 60 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.43734508 |
| 61 | L-phenylalanine catabolic process (GO:0006559) | 4.43734508 |
| 62 | hormone catabolic process (GO:0042447) | 4.43288078 |
| 63 | modified amino acid transport (GO:0072337) | 4.41920659 |
| 64 | regulation of cGMP metabolic process (GO:0030823) | 4.38840323 |
| 65 | cellular modified amino acid catabolic process (GO:0042219) | 4.32141518 |
| 66 | urea metabolic process (GO:0019627) | 4.31048132 |
| 67 | urea cycle (GO:0000050) | 4.27814627 |
| 68 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.27566952 |
| 69 | serine family amino acid metabolic process (GO:0009069) | 4.23574916 |
| 70 | fatty acid beta-oxidation (GO:0006635) | 4.22739493 |
| 71 | aromatic amino acid family catabolic process (GO:0009074) | 4.22714244 |
| 72 | regulation of triglyceride catabolic process (GO:0010896) | 4.16038515 |
| 73 | metanephric nephron epithelium development (GO:0072243) | 4.12746731 |
| 74 | bile acid metabolic process (GO:0008206) | 4.11870107 |
| 75 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.11667598 |
| 76 | sulfate transmembrane transport (GO:1902358) | 4.11098050 |
| 77 | amino-acid betaine transport (GO:0015838) | 4.01964880 |
| 78 | carnitine transport (GO:0015879) | 4.01964880 |
| 79 | indole-containing compound catabolic process (GO:0042436) | 3.98773117 |
| 80 | indolalkylamine catabolic process (GO:0046218) | 3.98773117 |
| 81 | tryptophan catabolic process (GO:0006569) | 3.98773117 |
| 82 | nitrogen cycle metabolic process (GO:0071941) | 3.98690417 |
| 83 | positive regulation of cGMP metabolic process (GO:0030825) | 3.97690408 |
| 84 | regulation of systemic arterial blood pressure (GO:0003073) | 3.96449839 |
| 85 | serine family amino acid catabolic process (GO:0009071) | 3.94400948 |
| 86 | glycosylceramide metabolic process (GO:0006677) | 3.85521044 |
| 87 | 2-oxoglutarate metabolic process (GO:0006103) | 3.85015293 |
| 88 | fatty acid oxidation (GO:0019395) | 3.81861518 |
| 89 | amino-acid betaine metabolic process (GO:0006577) | 3.80918261 |
| 90 | ketone body metabolic process (GO:1902224) | 3.80855130 |
| 91 | glycoside metabolic process (GO:0016137) | 3.78841733 |
| 92 | tryptophan metabolic process (GO:0006568) | 3.78380291 |
| 93 | serine family amino acid biosynthetic process (GO:0009070) | 3.76462821 |
| 94 | sulfur amino acid catabolic process (GO:0000098) | 3.75123334 |
| 95 | glycosphingolipid catabolic process (GO:0046479) | 3.74402829 |
| 96 | lipid oxidation (GO:0034440) | 3.73564767 |
| 97 | metanephric epithelium development (GO:0072207) | 3.71451275 |
| 98 | peptide biosynthetic process (GO:0043043) | 3.69379061 |
| 99 | response to phenylpropanoid (GO:0080184) | 3.66736513 |
| 100 | glycolipid catabolic process (GO:0019377) | 3.65908610 |
| 101 | fructose metabolic process (GO:0006000) | 3.64493865 |
| 102 | sodium-independent organic anion transport (GO:0043252) | 3.62284478 |
| 103 | renal system process involved in regulation of blood volume (GO:0001977) | 3.62155882 |
| 104 | response to growth hormone (GO:0060416) | 3.60735683 |
| 105 | nephron tubule development (GO:0072080) | 3.58920555 |
| 106 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.58590747 |
| 107 | fatty acid catabolic process (GO:0009062) | 3.55686197 |
| 108 | positive regulation of digestive system process (GO:0060456) | 3.53853316 |
| 109 | cobalamin metabolic process (GO:0009235) | 3.52167330 |
| 110 | cellular amino acid catabolic process (GO:0009063) | 3.51304893 |
| 111 | transepithelial transport (GO:0070633) | 3.49659450 |
| 112 | response to thyroid hormone (GO:0097066) | 3.49255905 |
| 113 | acetyl-CoA metabolic process (GO:0006084) | 3.47507313 |
| 114 | carnitine metabolic process (GO:0009437) | 3.45604567 |
| 115 | glutathione metabolic process (GO:0006749) | 3.44696271 |
| 116 | ethanol oxidation (GO:0006069) | 3.44346482 |
| 117 | biotin metabolic process (GO:0006768) | 3.43463712 |
| 118 | regulation of cellular extravasation (GO:0002691) | 3.43393491 |
| 119 | positive regulation of lipid catabolic process (GO:0050996) | 3.38567374 |
| 120 | glutathione derivative metabolic process (GO:1901685) | 3.38433145 |
| 121 | glutathione derivative biosynthetic process (GO:1901687) | 3.38433145 |
| 122 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.38285440 |
| 123 | sphingomyelin metabolic process (GO:0006684) | 3.34472034 |
| 124 | sulfate transport (GO:0008272) | 3.33293148 |
| 125 | glutamate metabolic process (GO:0006536) | 3.33160253 |
| 126 | regulation of cholesterol homeostasis (GO:2000188) | 3.33111507 |
| 127 | drug metabolic process (GO:0017144) | 3.32933944 |
| 128 | NADH metabolic process (GO:0006734) | 3.32891058 |
| 129 | nephron epithelium morphogenesis (GO:0072088) | 3.30286596 |
| 130 | nephron tubule morphogenesis (GO:0072078) | 3.30286596 |
| 131 | vitamin transport (GO:0051180) | 3.30168764 |
| 132 | digestion (GO:0007586) | 3.30060088 |
| 133 | cGMP biosynthetic process (GO:0006182) | 3.29966582 |
| 134 | virion attachment to host cell (GO:0019062) | 3.29096674 |
| 135 | adhesion of symbiont to host cell (GO:0044650) | 3.29096674 |
| 136 | alpha-amino acid catabolic process (GO:1901606) | 3.27437648 |
| 137 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.26943659 |
| 138 | negative regulation of steroid metabolic process (GO:0045939) | 3.26517316 |
| 139 | regulation of vitamin metabolic process (GO:0030656) | 3.26066794 |
| 140 | alkaloid metabolic process (GO:0009820) | 3.24431437 |
| 141 | carboxylic acid catabolic process (GO:0046395) | 3.23038731 |
| 142 | organic acid catabolic process (GO:0016054) | 3.23038731 |
| 143 | sulfur compound transport (GO:0072348) | 3.22896066 |
| 144 | monocarboxylic acid catabolic process (GO:0072329) | 3.22739475 |
| 145 | lipoprotein metabolic process (GO:0042157) | 3.21808301 |
| 146 | oligosaccharide catabolic process (GO:0009313) | 3.21403849 |
| 147 | actin filament depolymerization (GO:0030042) | 3.18574865 |
| 148 | renal tubule development (GO:0061326) | 3.17949776 |
| 149 | arginine metabolic process (GO:0006525) | 3.14748081 |
| 150 | aromatic amino acid family metabolic process (GO:0009072) | 3.12932394 |
| 151 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.11953397 |
| 152 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.11298361 |
| 153 | adhesion of symbiont to host (GO:0044406) | 3.08199866 |
| 154 | succinate metabolic process (GO:0006105) | 3.07968254 |
| 155 | diacylglycerol metabolic process (GO:0046339) | 3.05014886 |
| 156 | peptide hormone processing (GO:0016486) | 3.01079219 |
| 157 | phospholipid efflux (GO:0033700) | 3.00951756 |
| 158 | ceramide catabolic process (GO:0046514) | 3.00215279 |
| 159 | cellular response to vitamin D (GO:0071305) | 2.99419161 |
| 160 | fat-soluble vitamin metabolic process (GO:0006775) | 2.99073987 |
| 161 | digestive system process (GO:0022600) | 2.94979744 |
| 162 | positive regulation of icosanoid secretion (GO:0032305) | 2.94494752 |
| 163 | omega-hydroxylase P450 pathway (GO:0097267) | 2.93360849 |
| 164 | citrulline biosynthetic process (GO:0019240) | 2.92749244 |
| 165 | drinking behavior (GO:0042756) | 2.92570459 |
| 166 | antibacterial humoral response (GO:0019731) | 2.90612109 |
| 167 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.90525554 |
| 168 | plasma lipoprotein particle assembly (GO:0034377) | 2.87466946 |
| 169 | regulation of protein glycosylation (GO:0060049) | 2.85621107 |
| 170 | daunorubicin metabolic process (GO:0044597) | 2.85420520 |
| 171 | polyketide metabolic process (GO:0030638) | 2.85420520 |
| 172 | doxorubicin metabolic process (GO:0044598) | 2.85420520 |
| 173 | phenylpropanoid metabolic process (GO:0009698) | 2.85166340 |
| 174 | sodium ion homeostasis (GO:0055078) | 2.84634807 |
| 175 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.84411510 |
| 176 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.83924230 |
| 177 | regulation of cholesterol esterification (GO:0010872) | 2.83617154 |
| 178 | transcytosis (GO:0045056) | 2.82487465 |
| 179 | cGMP-mediated signaling (GO:0019934) | 2.80432760 |
| 180 | glucose 6-phosphate metabolic process (GO:0051156) | 2.78680958 |
| 181 | regulation of extracellular matrix disassembly (GO:0010715) | 2.78285896 |
| 182 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.77267420 |
| 183 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.76420682 |
| 184 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.76420682 |
| 185 | antimicrobial humoral response (GO:0019730) | 2.74964566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.40204314 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.62170457 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.28934906 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.92513349 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.89204530 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.84015850 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.52718321 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.44504028 |
| 9 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.42565280 |
| 10 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 3.37932491 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.32594169 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.26978561 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.23175819 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.78585009 |
| 15 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.74751137 |
| 16 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.72113059 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.51213043 |
| 18 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.33606281 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.30768423 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.29548566 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.17499306 |
| 22 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.00203837 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.98936108 |
| 24 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.97342972 |
| 25 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.88033657 |
| 26 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.87973369 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.87907664 |
| 28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.87394619 |
| 29 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.87275797 |
| 30 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.86920809 |
| 31 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.86424751 |
| 32 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.74799198 |
| 33 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.68936848 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.67982302 |
| 35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.61777903 |
| 36 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.61248622 |
| 37 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.61054088 |
| 38 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.60700005 |
| 39 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.60365169 |
| 40 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.53640296 |
| 41 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53260202 |
| 42 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.48199110 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.45827920 |
| 44 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.44556944 |
| 45 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.38749633 |
| 46 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.37950306 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37034562 |
| 48 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.30601294 |
| 49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.29435226 |
| 50 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.27448167 |
| 51 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25937545 |
| 52 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.24143095 |
| 53 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.23116776 |
| 54 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.21882564 |
| 55 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.20050274 |
| 56 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.18390420 |
| 57 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16239252 |
| 58 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.15888654 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.14388604 |
| 60 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.13945667 |
| 61 | GATA2_19941826_ChIP-Seq_K562_Human | 1.12880400 |
| 62 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10760986 |
| 63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.10060085 |
| 64 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.08915312 |
| 65 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08253285 |
| 66 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08175860 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07937062 |
| 68 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.05449724 |
| 69 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04950489 |
| 70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04370193 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02828303 |
| 72 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.02635164 |
| 73 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02366685 |
| 74 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02171203 |
| 75 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02171203 |
| 76 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.00524966 |
| 77 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99893875 |
| 78 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99741776 |
| 79 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.97709372 |
| 80 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97430931 |
| 81 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.96795776 |
| 82 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96121597 |
| 83 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.94556940 |
| 84 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94144826 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93917068 |
| 86 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.93103703 |
| 87 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92693331 |
| 88 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92638906 |
| 89 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90150956 |
| 90 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.90029630 |
| 91 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.89950756 |
| 92 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89817772 |
| 93 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89782324 |
| 94 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.89290273 |
| 95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88810291 |
| 96 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.88492460 |
| 97 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87611653 |
| 98 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.87024733 |
| 99 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.85734002 |
| 100 | VDR_22108803_ChIP-Seq_LS180_Human | 0.85313886 |
| 101 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.85250436 |
| 102 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.84854198 |
| 103 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.84417717 |
| 104 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.84312672 |
| 105 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.83667311 |
| 106 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.82627951 |
| 107 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.82327659 |
| 108 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.80981465 |
| 109 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.80981465 |
| 110 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.80853477 |
| 111 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.79056228 |
| 112 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.78713014 |
| 113 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78406175 |
| 114 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.78172643 |
| 115 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.77570471 |
| 116 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.76673211 |
| 117 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.76629649 |
| 118 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76083255 |
| 119 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75698661 |
| 120 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75698661 |
| 121 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.75575918 |
| 122 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.74802515 |
| 123 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.74636003 |
| 124 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74329813 |
| 125 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.73760998 |
| 126 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.73235184 |
| 127 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72576272 |
| 128 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.71751001 |
| 129 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.71584608 |
| 130 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.71289053 |
| 131 | NFYA_21822215_ChIP-Seq_K562_Human | 0.71157409 |
| 132 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.70600074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.45758502 |
| 2 | MP0004043_abnormal_pH_regulation | 5.27614105 |
| 3 | MP0005332_abnormal_amino_acid | 4.45046104 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 4.28804569 |
| 5 | MP0004019_abnormal_vitamin_homeostasis | 4.21725720 |
| 6 | MP0003183_abnormal_peptide_metabolism | 4.02591673 |
| 7 | MP0009643_abnormal_urine_homeostasis | 3.71508266 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 3.60605924 |
| 9 | MP0001958_emphysema | 3.55154350 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 3.29308890 |
| 11 | MP0005083_abnormal_biliary_tract | 3.25069679 |
| 12 | MP0001765_abnormal_ion_homeostasis | 3.09199172 |
| 13 | MP0005365_abnormal_bile_salt | 2.97281361 |
| 14 | MP0003195_calcinosis | 2.90253359 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.90015242 |
| 16 | MP0001756_abnormal_urination | 2.80513976 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.71980098 |
| 18 | MP0002136_abnormal_kidney_physiology | 2.68580171 |
| 19 | MP0005636_abnormal_mineral_homeostasis | 2.66258037 |
| 20 | MP0003252_abnormal_bile_duct | 2.45316349 |
| 21 | MP0009840_abnormal_foam_cell | 2.39899896 |
| 22 | MP0005377_hearing/vestibular/ear_phenot | 2.28680205 |
| 23 | MP0003878_abnormal_ear_physiology | 2.28680205 |
| 24 | MP0005084_abnormal_gallbladder_morpholo | 2.12564093 |
| 25 | MP0003941_abnormal_skin_development | 1.85984235 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.77994635 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.70275159 |
| 28 | MP0005220_abnormal_exocrine_pancreas | 1.66214816 |
| 29 | MP0000538_abnormal_urinary_bladder | 1.63991015 |
| 30 | MP0004782_abnormal_surfactant_physiolog | 1.62297240 |
| 31 | MP0003866_abnormal_defecation | 1.62250240 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.58442780 |
| 33 | MP0004264_abnormal_extraembryonic_tissu | 1.48276670 |
| 34 | MP0008961_abnormal_basal_metabolism | 1.45494090 |
| 35 | MP0003186_abnormal_redox_activity | 1.45342651 |
| 36 | MP0005670_abnormal_white_adipose | 1.40780749 |
| 37 | MP0010352_gastrointestinal_tract_polyps | 1.36673875 |
| 38 | MP0008004_abnormal_stomach_pH | 1.35164790 |
| 39 | MP0003879_abnormal_hair_cell | 1.30405681 |
| 40 | MP0002928_abnormal_bile_duct | 1.23320014 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.21517208 |
| 42 | MP0002876_abnormal_thyroid_physiology | 1.18832570 |
| 43 | MP0000477_abnormal_intestine_morphology | 1.17215192 |
| 44 | MP0003806_abnormal_nucleotide_metabolis | 1.16369410 |
| 45 | MP0004272_abnormal_basement_membrane | 1.16306689 |
| 46 | MP0001664_abnormal_digestion | 1.13808110 |
| 47 | MP0001873_stomach_inflammation | 1.12062339 |
| 48 | MP0005166_decreased_susceptibility_to | 1.11270333 |
| 49 | MP0002135_abnormal_kidney_morphology | 1.10456690 |
| 50 | MP0005408_hypopigmentation | 1.09584870 |
| 51 | MP0005319_abnormal_enzyme/_coenzyme | 1.05878597 |
| 52 | MP0003283_abnormal_digestive_organ | 1.05375959 |
| 53 | MP0010234_abnormal_vibrissa_follicle | 1.04443891 |
| 54 | MP0000230_abnormal_systemic_arterial | 1.02459048 |
| 55 | MP0005451_abnormal_body_composition | 1.01382890 |
| 56 | MP0002118_abnormal_lipid_homeostasis | 0.98369786 |
| 57 | MP0002168_other_aberrant_phenotype | 0.98207660 |
| 58 | MP0003959_abnormal_lean_body | 0.97669485 |
| 59 | MP0006082_CNS_inflammation | 0.96968971 |
| 60 | MP0004885_abnormal_endolymph | 0.96517022 |
| 61 | MP0001542_abnormal_bone_strength | 0.95207361 |
| 62 | MP0009785_altered_susceptibility_to | 0.93201963 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 0.92855357 |
| 64 | MP0001177_atelectasis | 0.92784455 |
| 65 | MP0002089_abnormal_postnatal_growth/wei | 0.89166442 |
| 66 | MP0002796_impaired_skin_barrier | 0.88609403 |
| 67 | MP0001501_abnormal_sleep_pattern | 0.87582626 |
| 68 | MP0000462_abnormal_digestive_system | 0.86468859 |
| 69 | MP0003638_abnormal_response/metabolism_ | 0.86343883 |
| 70 | MP0008995_early_reproductive_senescence | 0.86094119 |
| 71 | MP0001764_abnormal_homeostasis | 0.85667812 |
| 72 | MP0002098_abnormal_vibrissa_morphology | 0.84764887 |
| 73 | MP0009697_abnormal_copulation | 0.83410279 |
| 74 | MP0002896_abnormal_bone_mineralization | 0.83061233 |
| 75 | MP0003950_abnormal_plasma_membrane | 0.81936351 |
| 76 | MP0009384_cardiac_valve_regurgitation | 0.81424933 |
| 77 | MP0006036_abnormal_mitochondrial_physio | 0.79797675 |
| 78 | MP0010329_abnormal_lipoprotein_level | 0.79030898 |
| 79 | MP0004883_abnormal_blood_vessel | 0.77898439 |
| 80 | MP0008872_abnormal_physiological_respon | 0.77062705 |
| 81 | MP0002971_abnormal_brown_adipose | 0.75376208 |
| 82 | MP0001663_abnormal_digestive_system | 0.73648920 |
| 83 | MP0005409_darkened_coat_color | 0.71448112 |
| 84 | MP0006054_spinal_hemorrhage | 0.70930744 |
| 85 | MP0001845_abnormal_inflammatory_respons | 0.70640704 |
| 86 | MP0005388_respiratory_system_phenotype | 0.70487725 |
| 87 | MP0002133_abnormal_respiratory_system | 0.70487725 |
| 88 | MP0005310_abnormal_salivary_gland | 0.70391313 |
| 89 | MP0003718_maternal_effect | 0.68938924 |
| 90 | MP0000249_abnormal_blood_vessel | 0.68858883 |
| 91 | MP0000537_abnormal_urethra_morphology | 0.68787869 |
| 92 | MP0005381_digestive/alimentary_phenotyp | 0.68322974 |
| 93 | MP0002254_reproductive_system_inflammat | 0.67910686 |
| 94 | MP0005535_abnormal_body_temperature | 0.67661352 |
| 95 | MP0002166_altered_tumor_susceptibility | 0.64841621 |
| 96 | MP0002396_abnormal_hematopoietic_system | 0.63441727 |
| 97 | MP0009642_abnormal_blood_homeostasis | 0.63236591 |
| 98 | MP0010678_abnormal_skin_adnexa | 0.63043175 |
| 99 | MP0010386_abnormal_urinary_bladder | 0.62514666 |
| 100 | MP0005595_abnormal_vascular_smooth | 0.60755177 |
| 101 | MP0005501_abnormal_skin_physiology | 0.60666750 |
| 102 | MP0003724_increased_susceptibility_to | 0.58719892 |
| 103 | MP0005395_other_phenotype | 0.57941817 |
| 104 | MP0000609_abnormal_liver_physiology | 0.57816274 |
| 105 | MP0005448_abnormal_energy_balance | 0.57048369 |
| 106 | MP0003115_abnormal_respiratory_system | 0.56806398 |
| 107 | MP0009780_abnormal_chondrocyte_physiolo | 0.56082783 |
| 108 | MP0003123_paternal_imprinting | 0.54552942 |
| 109 | MP0005376_homeostasis/metabolism_phenot | 0.53800416 |
| 110 | MP0005666_abnormal_adipose_tissue | 0.53409067 |
| 111 | MP0004233_abnormal_muscle_weight | 0.53121986 |
| 112 | MP0005165_increased_susceptibility_to | 0.52583765 |
| 113 | MP0000678_abnormal_parathyroid_gland | 0.52296489 |
| 114 | MP0009115_abnormal_fat_cell | 0.51553696 |
| 115 | MP0000490_abnormal_crypts_of | 0.51171626 |
| 116 | MP0002998_abnormal_bone_remodeling | 0.50886443 |
| 117 | MP0004147_increased_porphyrin_level | 0.50520092 |
| 118 | MP0004484_altered_response_of | 0.50083897 |
| 119 | MP0010155_abnormal_intestine_physiology | 0.49628113 |
| 120 | MP0000465_gastrointestinal_hemorrhage | 0.49212383 |
| 121 | MP0003303_peritoneal_inflammation | 0.48642115 |
| 122 | MP0001790_abnormal_immune_system | 0.46616907 |
| 123 | MP0005387_immune_system_phenotype | 0.46616907 |
| 124 | MP0002078_abnormal_glucose_homeostasis | 0.45481381 |
| 125 | MP0009764_decreased_sensitivity_to | 0.45416697 |
| 126 | MP0006138_congestive_heart_failure | 0.44676094 |
| 127 | MP0004215_abnormal_myocardial_fiber | 0.43751824 |
| 128 | MP0004858_abnormal_nervous_system | 0.42773624 |
| 129 | MP0008775_abnormal_heart_ventricle | 0.42633806 |
| 130 | MP0009379_abnormal_foot_pigmentation | 0.42500239 |
| 131 | MP0003868_abnormal_feces_composition | 0.42435001 |
| 132 | MP0003045_fibrosis | 0.41986400 |
| 133 | MP0000598_abnormal_liver_morphology | 0.40903979 |
| 134 | MP0002009_preneoplasia | 0.40626903 |
| 135 | MP0003795_abnormal_bone_structure | 0.39353149 |
| 136 | MP0003953_abnormal_hormone_level | 0.39340399 |
| 137 | MP0008469_abnormal_protein_level | 0.39193448 |
| 138 | MP0005025_abnormal_response_to | 0.38262962 |
| 139 | MP0002006_tumorigenesis | 0.37509479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gout (HP:0001997) | 7.96188967 |
| 2 | Hyperactive renin-angiotensin system (HP:0000841) | 7.03736622 |
| 3 | Increased circulating renin level (HP:0000848) | 6.82978969 |
| 4 | Hypokalemic alkalosis (HP:0001949) | 6.70831267 |
| 5 | Metabolic alkalosis (HP:0200114) | 6.60579546 |
| 6 | Abnormality of chloride homeostasis (HP:0011422) | 6.56133206 |
| 7 | Hypomagnesemia (HP:0002917) | 6.18385896 |
| 8 | Abnormality of renal excretion (HP:0011036) | 5.72788575 |
| 9 | Polyuria (HP:0000103) | 5.71795748 |
| 10 | Increased purine levels (HP:0004368) | 5.52926765 |
| 11 | Hyperuricemia (HP:0002149) | 5.52926765 |
| 12 | Abnormal urine output (HP:0012590) | 5.43957681 |
| 13 | Renal salt wasting (HP:0000127) | 5.40240627 |
| 14 | Abnormality of magnesium homeostasis (HP:0004921) | 5.27467757 |
| 15 | Proximal tubulopathy (HP:0000114) | 5.06857285 |
| 16 | Hypobetalipoproteinemia (HP:0003563) | 4.85528411 |
| 17 | Abnormality of purine metabolism (HP:0004352) | 4.71389539 |
| 18 | Abnormality of renin-angiotensin system (HP:0000847) | 4.59407900 |
| 19 | Abnormal drinking behavior (HP:0030082) | 4.55291380 |
| 20 | Polydipsia (HP:0001959) | 4.55291380 |
| 21 | Hyperglycinuria (HP:0003108) | 4.51342068 |
| 22 | Hyperaldosteronism (HP:0000859) | 4.47812497 |
| 23 | Alkalosis (HP:0001948) | 4.45278700 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.39804278 |
| 25 | Tetany (HP:0001281) | 4.36877058 |
| 26 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.15457515 |
| 27 | Fat malabsorption (HP:0002630) | 3.98730315 |
| 28 | Glycosuria (HP:0003076) | 3.87028663 |
| 29 | Abnormality of urine glucose concentration (HP:0011016) | 3.87028663 |
| 30 | Thin bony cortex (HP:0002753) | 3.75520069 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.74249888 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 3.74249888 |
| 33 | Hypercalciuria (HP:0002150) | 3.72433427 |
| 34 | Generalized aminoaciduria (HP:0002909) | 3.66295372 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.65433296 |
| 36 | Tubulointerstitial fibrosis (HP:0005576) | 3.64778213 |
| 37 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.55424603 |
| 38 | Chronic diarrhea (HP:0002028) | 3.55028379 |
| 39 | Ketoacidosis (HP:0001993) | 3.49584799 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.46048305 |
| 41 | Hypokalemia (HP:0002900) | 3.41722207 |
| 42 | Acanthocytosis (HP:0001927) | 3.36998442 |
| 43 | Abnormality of vitamin B metabolism (HP:0004340) | 3.27199395 |
| 44 | Intrahepatic cholestasis (HP:0001406) | 3.18875057 |
| 45 | Renal tubular acidosis (HP:0001947) | 3.13466189 |
| 46 | Pigmentary retinal degeneration (HP:0001146) | 3.12791452 |
| 47 | Hyperphosphaturia (HP:0003109) | 3.11644697 |
| 48 | Ketosis (HP:0001946) | 3.00935740 |
| 49 | Abnormality of potassium homeostasis (HP:0011042) | 2.97861638 |
| 50 | Flat acetabular roof (HP:0003180) | 2.95826838 |
| 51 | Abnormal urine phosphate concentration (HP:0012599) | 2.91341102 |
| 52 | Delayed epiphyseal ossification (HP:0002663) | 2.90668650 |
| 53 | Abnormality of vitamin metabolism (HP:0100508) | 2.90324588 |
| 54 | Focal segmental glomerulosclerosis (HP:0000097) | 2.88594596 |
| 55 | Tubular atrophy (HP:0000092) | 2.84793460 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.83830169 |
| 57 | Abdominal distention (HP:0003270) | 2.80666966 |
| 58 | Complement deficiency (HP:0004431) | 2.75881923 |
| 59 | Abnormality of proline metabolism (HP:0010907) | 2.74562855 |
| 60 | Hydroxyprolinuria (HP:0003080) | 2.74562855 |
| 61 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.74392383 |
| 62 | Hemorrhage of the eye (HP:0011885) | 2.74289588 |
| 63 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.74230862 |
| 64 | Dehydration (HP:0001944) | 2.73005792 |
| 65 | Malnutrition (HP:0004395) | 2.70690064 |
| 66 | Glomerulonephritis (HP:0000099) | 2.62475389 |
| 67 | Hyperammonemia (HP:0001987) | 2.52245916 |
| 68 | Nephrolithiasis (HP:0000787) | 2.51686523 |
| 69 | Hyperglycinemia (HP:0002154) | 2.50988533 |
| 70 | Xanthomatosis (HP:0000991) | 2.50760046 |
| 71 | Neonatal onset (HP:0003623) | 2.48233192 |
| 72 | Widely patent fontanelles and sutures (HP:0004492) | 2.47423923 |
| 73 | Nephrocalcinosis (HP:0000121) | 2.45485032 |
| 74 | Vascular calcification (HP:0004934) | 2.44886700 |
| 75 | Abnormality of complement system (HP:0005339) | 2.44511413 |
| 76 | Hypophosphatemia (HP:0002148) | 2.43017553 |
| 77 | Right ventricular cardiomyopathy (HP:0011663) | 2.41207294 |
| 78 | Delayed CNS myelination (HP:0002188) | 2.39883785 |
| 79 | Tubulointerstitial abnormality (HP:0001969) | 2.39799946 |
| 80 | Hypolipoproteinemia (HP:0010981) | 2.39062078 |
| 81 | Late onset (HP:0003584) | 2.38380815 |
| 82 | Rickets (HP:0002748) | 2.37673410 |
| 83 | Hyponatremia (HP:0002902) | 2.35643272 |
| 84 | Metabolic acidosis (HP:0001942) | 2.34555777 |
| 85 | Tachypnea (HP:0002789) | 2.34375915 |
| 86 | Steatorrhea (HP:0002570) | 2.32459059 |
| 87 | Ileus (HP:0002595) | 2.32113936 |
| 88 | Enlarged kidneys (HP:0000105) | 2.31359420 |
| 89 | Abnormality of sodium homeostasis (HP:0010931) | 2.26269488 |
| 90 | Vacuolated lymphocytes (HP:0001922) | 2.24663349 |
| 91 | Glomerulosclerosis (HP:0000096) | 2.24008081 |
| 92 | Dicarboxylic aciduria (HP:0003215) | 2.23848537 |
| 93 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.23848537 |
| 94 | Hypotension (HP:0002615) | 2.21862744 |
| 95 | Abnormality of renal resorption (HP:0011038) | 2.19772753 |
| 96 | Cardiovascular calcification (HP:0011915) | 2.17553102 |
| 97 | Bicornuate uterus (HP:0000813) | 2.15642044 |
| 98 | Renal tubular dysfunction (HP:0000124) | 2.11728973 |
| 99 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.09643023 |
| 100 | Vomiting (HP:0002013) | 2.07088240 |
| 101 | Adrenal overactivity (HP:0002717) | 2.06346261 |
| 102 | Abnormality of the renal cortex (HP:0011035) | 2.05896688 |
| 103 | Abnormal glucose tolerance (HP:0001952) | 2.05860087 |
| 104 | Abnormality of the costochondral junction (HP:0000919) | 2.04235286 |
| 105 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.04071456 |
| 106 | Metaphyseal cupping (HP:0003021) | 2.04043518 |
| 107 | Wide cranial sutures (HP:0010537) | 2.02340656 |
| 108 | Nephritis (HP:0000123) | 2.01718260 |
| 109 | Potter facies (HP:0002009) | 2.00284937 |
| 110 | Facial shape deformation (HP:0011334) | 2.00284937 |
| 111 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.98385769 |
| 112 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93559368 |
| 113 | Elevated alkaline phosphatase (HP:0003155) | 1.93031961 |
| 114 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.92250632 |
| 115 | Tubulointerstitial nephritis (HP:0001970) | 1.91272306 |
| 116 | Enlarged epiphyses (HP:0010580) | 1.90730894 |
| 117 | Confusion (HP:0001289) | 1.90041413 |
| 118 | Megaloblastic anemia (HP:0001889) | 1.88826084 |
| 119 | Lethargy (HP:0001254) | 1.88231760 |
| 120 | Hyperkalemia (HP:0002153) | 1.87575494 |
| 121 | Decreased circulating renin level (HP:0003351) | 1.87512277 |
| 122 | Osteomalacia (HP:0002749) | 1.87335379 |
| 123 | Abnormal tarsal ossification (HP:0008369) | 1.86513443 |
| 124 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.86172428 |
| 125 | Chondrocalcinosis (HP:0000934) | 1.85235764 |
| 126 | Hypophosphatemic rickets (HP:0004912) | 1.82704876 |
| 127 | Congenital sensorineural hearing impairment (HP:0008527) | 1.82344850 |
| 128 | Irritability (HP:0000737) | 1.82236824 |
| 129 | Nausea (HP:0002018) | 1.81042190 |
| 130 | Interstitial pulmonary disease (HP:0006530) | 1.78860838 |
| 131 | Abnormal pancreas size (HP:0012094) | 1.77077105 |
| 132 | Abnormality of Sharpey fibers (HP:0100685) | 1.75311927 |
| 133 | Methylmalonic aciduria (HP:0012120) | 1.72652206 |
| 134 | Metaphyseal irregularity (HP:0003025) | 1.69776462 |
| 135 | Abnormality of serum amino acid levels (HP:0003112) | 1.69027092 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 7.75860287 |
| 2 | ACVR1B | 6.60247592 |
| 3 | WNK3 | 6.40886628 |
| 4 | OXSR1 | 6.23785883 |
| 5 | STK39 | 3.97671991 |
| 6 | BCKDK | 3.49287707 |
| 7 | PIK3CA | 2.79955745 |
| 8 | MAP3K3 | 2.64856649 |
| 9 | LMTK2 | 2.60493870 |
| 10 | MAP3K10 | 2.29258187 |
| 11 | MST4 | 2.28525052 |
| 12 | TNIK | 2.05641125 |
| 13 | TAOK2 | 2.02025771 |
| 14 | STK38L | 1.96072373 |
| 15 | NUAK1 | 1.90140972 |
| 16 | MAP3K11 | 1.89475153 |
| 17 | BLK | 1.85720582 |
| 18 | TAOK1 | 1.81115377 |
| 19 | MST1R | 1.78572291 |
| 20 | PDK3 | 1.77219581 |
| 21 | PDK4 | 1.77219581 |
| 22 | WNK1 | 1.64447911 |
| 23 | SGK494 | 1.61533606 |
| 24 | SGK223 | 1.61533606 |
| 25 | FRK | 1.57661043 |
| 26 | PDK2 | 1.51443506 |
| 27 | MAP2K3 | 1.49696038 |
| 28 | TGFBR2 | 1.35303521 |
| 29 | CASK | 1.24542451 |
| 30 | PRPF4B | 1.24404051 |
| 31 | EPHA3 | 1.21924592 |
| 32 | LRRK2 | 1.19986366 |
| 33 | EPHA4 | 1.10742364 |
| 34 | SGK2 | 1.03936906 |
| 35 | DDR2 | 1.01815332 |
| 36 | NEK1 | 1.01739694 |
| 37 | PAK4 | 1.00783405 |
| 38 | STK10 | 0.98134448 |
| 39 | SGK3 | 0.92069083 |
| 40 | EPHB1 | 0.87614600 |
| 41 | PTK6 | 0.86724688 |
| 42 | MATK | 0.78516569 |
| 43 | TESK1 | 0.77350731 |
| 44 | GSK3A | 0.76186328 |
| 45 | MAP2K6 | 0.74358343 |
| 46 | ERN1 | 0.73614770 |
| 47 | STK38 | 0.72408384 |
| 48 | MYLK | 0.71874791 |
| 49 | FGFR3 | 0.70632173 |
| 50 | ZAP70 | 0.68660338 |
| 51 | PTK2 | 0.67951573 |
| 52 | EPHA2 | 0.66664132 |
| 53 | TRIB3 | 0.66623907 |
| 54 | MAP2K2 | 0.66254635 |
| 55 | AKT3 | 0.66144144 |
| 56 | EPHB2 | 0.64593793 |
| 57 | BMPR2 | 0.64454855 |
| 58 | DAPK2 | 0.63320206 |
| 59 | FGFR4 | 0.60487970 |
| 60 | RIPK4 | 0.59202113 |
| 61 | FER | 0.59124713 |
| 62 | MAP3K2 | 0.56341306 |
| 63 | PRKG2 | 0.56140861 |
| 64 | FGFR2 | 0.56120657 |
| 65 | NME1 | 0.55801774 |
| 66 | MAP3K14 | 0.54409930 |
| 67 | PIM1 | 0.53265503 |
| 68 | DYRK1B | 0.52088058 |
| 69 | IRAK3 | 0.51961647 |
| 70 | MAP3K7 | 0.51657773 |
| 71 | DAPK3 | 0.51634334 |
| 72 | TBK1 | 0.50886539 |
| 73 | SYK | 0.49808683 |
| 74 | TYK2 | 0.49554625 |
| 75 | MAP4K1 | 0.48576736 |
| 76 | SRC | 0.46587004 |
| 77 | PRKAA2 | 0.46392096 |
| 78 | MAP3K12 | 0.46349338 |
| 79 | PRKCI | 0.45818955 |
| 80 | CSF1R | 0.43348246 |
| 81 | MET | 0.42634633 |
| 82 | ILK | 0.42538727 |
| 83 | GRK6 | 0.41920574 |
| 84 | PBK | 0.41731474 |
| 85 | NEK9 | 0.41383202 |
| 86 | GRK5 | 0.41310413 |
| 87 | BMX | 0.41302098 |
| 88 | PRKAA1 | 0.38676670 |
| 89 | MAPK11 | 0.37469234 |
| 90 | JAK1 | 0.37224126 |
| 91 | TIE1 | 0.37114345 |
| 92 | ERBB2 | 0.36909606 |
| 93 | RIPK1 | 0.36689946 |
| 94 | SGK1 | 0.36562203 |
| 95 | CDC42BPA | 0.33956288 |
| 96 | IRAK1 | 0.33892614 |
| 97 | CAMK2D | 0.33738295 |
| 98 | PINK1 | 0.32960156 |
| 99 | TEC | 0.32899601 |
| 100 | PDGFRB | 0.31173055 |
| 101 | ITK | 0.30798217 |
| 102 | PKN2 | 0.30165849 |
| 103 | PRKCQ | 0.29140220 |
| 104 | NTRK3 | 0.29024580 |
| 105 | EIF2AK3 | 0.28394353 |
| 106 | ROCK1 | 0.28331841 |
| 107 | MAP3K1 | 0.28298103 |
| 108 | MAPK7 | 0.28087350 |
| 109 | LYN | 0.27806089 |
| 110 | PIK3CG | 0.27480159 |
| 111 | MELK | 0.26879161 |
| 112 | MAP2K1 | 0.26738790 |
| 113 | PRKCZ | 0.26479845 |
| 114 | MAPKAPK2 | 0.26036942 |
| 115 | BCR | 0.25283175 |
| 116 | FGR | 0.24036308 |
| 117 | LATS1 | 0.23979297 |
| 118 | TRPM7 | 0.23659735 |
| 119 | SMG1 | 0.23610139 |
| 120 | STK24 | 0.23407710 |
| 121 | GRK7 | 0.22830085 |
| 122 | MAP3K8 | 0.22603134 |
| 123 | PRKACG | 0.22403600 |
| 124 | PRKCD | 0.22158729 |
| 125 | FYN | 0.22100225 |
| 126 | TGFBR1 | 0.20864712 |
| 127 | NLK | 0.20857116 |
| 128 | ERBB4 | 0.19401800 |
| 129 | INSRR | 0.18650283 |
| 130 | MAPK15 | 0.18343839 |
| 131 | PDPK1 | 0.18120710 |
| 132 | LIMK1 | 0.16668512 |
| 133 | PRKCA | 0.15877125 |
| 134 | EGFR | 0.14256398 |
| 135 | PAK3 | 0.14154686 |
| 136 | GRK1 | 0.13106316 |
| 137 | TAOK3 | 0.12938962 |
| 138 | ABL2 | 0.11013553 |
| 139 | NME2 | 0.10773087 |
| 140 | IGF1R | 0.10677511 |
| 141 | MAP3K5 | 0.09276457 |
| 142 | PRKACA | 0.08749135 |
| 143 | PTK2B | 0.08138176 |
| 144 | PDK1 | 0.08082256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.71936463 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.59162548 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.45887331 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.34053176 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.15192118 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.14665640 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.07359146 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.91359749 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.77769150 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.73434453 |
| 11 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.42862919 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.36873622 |
| 13 | Peroxisome_Homo sapiens_hsa04146 | 2.33822674 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.29957579 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.23955552 |
| 16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.21762158 |
| 17 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.21598642 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.19864766 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.17443127 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.93975457 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.85755314 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.73946559 |
| 23 | Mineral absorption_Homo sapiens_hsa04978 | 1.71631328 |
| 24 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.66548142 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.64698767 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.59352164 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.59080430 |
| 28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.55071714 |
| 29 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.51073497 |
| 30 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.40839513 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.38087860 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35639159 |
| 33 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.29916683 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.28171173 |
| 35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.25131620 |
| 36 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.21333137 |
| 37 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.21307701 |
| 38 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.20697652 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 1.18443949 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.18092716 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17486160 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15168038 |
| 43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13672914 |
| 44 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.13423186 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10384262 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.06373695 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.04928155 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.03259491 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.01622701 |
| 50 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.01138299 |
| 51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.98131179 |
| 52 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.94855292 |
| 53 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.89188176 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.88452431 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.86672841 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86556010 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.83321624 |
| 58 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.82275617 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78928078 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68484473 |
| 61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67931546 |
| 62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.65538250 |
| 63 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65098768 |
| 64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.64561194 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.63923674 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61501877 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.59585476 |
| 68 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.59020557 |
| 69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58650356 |
| 70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.58626063 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.57637522 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55223181 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55079101 |
| 74 | Parkinsons disease_Homo sapiens_hsa05012 | 0.51167035 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.48539408 |
| 76 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48317505 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.46770644 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46576712 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45080018 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44814379 |
| 81 | Tight junction_Homo sapiens_hsa04530 | 0.42182713 |
| 82 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.41880038 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41600121 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.39262802 |
| 85 | Allograft rejection_Homo sapiens_hsa05330 | 0.38671499 |
| 86 | Bladder cancer_Homo sapiens_hsa05219 | 0.34160600 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.33776583 |
| 88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.33703192 |
| 89 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.33529074 |
| 90 | Renin secretion_Homo sapiens_hsa04924 | 0.33408075 |
| 91 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.32851097 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30799053 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28779280 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.25746046 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | 0.24807380 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.24502699 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.23589569 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22338926 |
| 99 | Alzheimers disease_Homo sapiens_hsa05010 | 0.20995424 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.20342734 |
| 101 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20188965 |
| 102 | Adherens junction_Homo sapiens_hsa04520 | 0.19771463 |
| 103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.18817093 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.17131956 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.16725172 |
| 106 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.16628363 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16378273 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15969902 |
| 109 | Sulfur relay system_Homo sapiens_hsa04122 | 0.14632090 |
| 110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.14053240 |
| 111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.12549215 |
| 112 | Huntingtons disease_Homo sapiens_hsa05016 | 0.11906906 |
| 113 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.11680564 |
| 114 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.11527119 |
| 115 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.09513837 |
| 116 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.08814995 |
| 117 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.08535490 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.04870559 |
| 119 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04737946 |
| 120 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.02531885 |
| 121 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.02487435 |
| 122 | Phototransduction_Homo sapiens_hsa04744 | 0.01901607 |
| 123 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.01312860 |

